Skip to content
Screener

Medline, Inc. MDLN Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$7.7BBeat by $166.2M
EPS$0.50Beat by $0.15
Revenue estimate$7.5B
EPS estimate$0.35
“Our second quarter results reflect strong execution of our growth strategy, and the operational resilience of our team. We delivered robust top-line growth in the quarter, secured over 65% of our annual goal in total new customer signings during the first half of 2026, and moved swiftly to minimize disruption from the fire at our Tracy, California distribution center, demonstrating an unwavering commitment to our customers. At the same time, we are effectively managing a dynamic external environment while investing in strategic initiatives to strengthen our market position and support long-term shareholder value creation.”
Jim Boyle

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.7B
EPS estimate$0.34

Financials

Q2 2026

Income statement

See full
Revenue$7.7B+11.6%
Gross profit$2.2B+16.3%
Operating income$395.0M-38.5%
Net income$139.0M-57.8%
EPS (diluted)$0.07—

Balance sheet

See full
Cash & equivalents$2.3B+299%
Total debt$12.6B—
Total equity$11.6B—
Total assets$39.4B—

Cash flow

See full
Operating cash flow$715.0M+263%
CapEx$111.0M+0.9%
Free cash flow$604.0M+594%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$30.34B-2.4%
Enterprise value$40.62B—
P/E34.1×—
P/S1.1×—

Returns & leverage

See full
Debt / equity1.1×—
Current ratio4.3×—

Segments

By product

See full
Front Line Care$1.7B+3.8%
Surgical Solutions$1.6B+8.7%
Laboratory and Diagnostics$248.0M+12.2%

By segment

See full
Supply Chain Solutions$4.1B+16.3%
Medline Brand$3.5B+6.6%

By geography

See full
International$533.0M+9.4%

Versus estimates

Revenue

Q2 2026$7.7BBeat by $166.2M
Q1 2026$7.4BBeat by $189.4MQ4 2025$7.8BBeat by $274.8MQ3 2025$7.1B

Diluted EPS

Q2 2026$0.50Beat by $0.15
Q1 2026$0.33Beat by $0.03Q4 2025$0.22Miss by $0.02Q3 2025$0.31

FAQ

When did Medline, Inc. report Q2 2026 earnings?
Medline, Inc. (MDLN) reported Q2 2026 earnings on August 5, 2026 before market open.
What were Medline, Inc.'s Q2 2026 revenue and EPS?
Medline, Inc. reported revenue of $7.7B and eps of $0.50 for Q2 2026.
Did Medline, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $7.5B by $166.2M. EPS beat the consensus estimate of $0.35 by $0.15.
Where can I find Medline, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0002046386-26-000049) and the 10-Q periodic report (0002046386-26-000051) directly on SEC EDGAR. The filing index links above go to sec.gov.